Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Implantable Cardioverter Defibrillator (ICD) Market Research Report 2019-2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Implantable Cardioverter Defibrillator (ICD) Industry
  • 1.7 COVID-19 Impact: Implantable Cardioverter Defibrillator (ICD) Market Trends

    • 2 Global Implantable Cardioverter Defibrillator (ICD) Quarterly Market Size Analysis

    • 2.1 Implantable Cardioverter Defibrillator (ICD) Business Impact Assessment - COVID-19
      • 2.1.1 Global Implantable Cardioverter Defibrillator (ICD) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Implantable Cardioverter Defibrillator (ICD) Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Implantable Cardioverter Defibrillator (ICD) Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Implantable Cardioverter Defibrillator (ICD) Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Implantable Cardioverter Defibrillator (ICD) Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Implantable Cardioverter Defibrillator (ICD) Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Implantable Cardioverter Defibrillator (ICD) Market
    • 3.5 Key Manufacturers Implantable Cardioverter Defibrillator (ICD) Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Implantable Cardioverter Defibrillator (ICD) Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Single Chamber ICD
      • 1.4.2 Dual Chamber ICD
      • 1.4.3 Biventricular ICD
    • 4.2 By Type, Global Implantable Cardioverter Defibrillator (ICD) Market Size, 2019-2021
      • 4.2.1 By Type, Global Implantable Cardioverter Defibrillator (ICD) Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Implantable Cardioverter Defibrillator (ICD) Price, 2020-2021

    5 Impact of Covid-19 on Implantable Cardioverter Defibrillator (ICD) Segments, By Application

    • 5.1 Overview
      • 5.5.1 Bradycardia
      • 5.5.2 Tachycardia
      • 5.5.3 Heart Failure
      • 5.5.4 Others
    • 5.2 By Application, Global Implantable Cardioverter Defibrillator (ICD) Market Size, 2019-2021
      • 5.2.1 By Application, Global Implantable Cardioverter Defibrillator (ICD) Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Implantable Cardioverter Defibrillator (ICD) Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Medtronic
      • 7.1.1 Medtronic Business Overview
      • 7.1.2 Medtronic Implantable Cardioverter Defibrillator (ICD) Quarterly Production and Revenue, 2020
      • 7.1.3 Medtronic Implantable Cardioverter Defibrillator (ICD) Product Introduction
      • 7.1.4 Medtronic Response to COVID-19 and Related Developments
    • 7.2 Abbott
      • 7.2.1 Abbott Business Overview
      • 7.2.2 Abbott Implantable Cardioverter Defibrillator (ICD) Quarterly Production and Revenue, 2020
      • 7.2.3 Abbott Implantable Cardioverter Defibrillator (ICD) Product Introduction
      • 7.2.4 Abbott Response to COVID-19 and Related Developments
    • 7.3 Boston Scientific
      • 7.3.1 Boston Scientific Business Overview
      • 7.3.2 Boston Scientific Implantable Cardioverter Defibrillator (ICD) Quarterly Production and Revenue, 2020
      • 7.3.3 Boston Scientific Implantable Cardioverter Defibrillator (ICD) Product Introduction
      • 7.3.4 Boston Scientific Response to COVID-19 and Related Developments
    • 7.4 Philips Healthcare
      • 7.4.1 Philips Healthcare Business Overview
      • 7.4.2 Philips Healthcare Implantable Cardioverter Defibrillator (ICD) Quarterly Production and Revenue, 2020
      • 7.4.3 Philips Healthcare Implantable Cardioverter Defibrillator (ICD) Product Introduction
      • 7.4.4 Philips Healthcare Response to COVID-19 and Related Developments
    • 7.5 Zoll Medical
      • 7.5.1 Zoll Medical Business Overview
      • 7.5.2 Zoll Medical Implantable Cardioverter Defibrillator (ICD) Quarterly Production and Revenue, 2020
      • 7.5.3 Zoll Medical Implantable Cardioverter Defibrillator (ICD) Product Introduction
      • 7.5.4 Zoll Medical Response to COVID-19 and Related Developments
    • 7.6 Biotronik Se
      • 7.6.1 Biotronik Se Business Overview
      • 7.6.2 Biotronik Se Implantable Cardioverter Defibrillator (ICD) Quarterly Production and Revenue, 2020
      • 7.6.3 Biotronik Se Implantable Cardioverter Defibrillator (ICD) Product Introduction
      • 7.6.4 Biotronik Se Response to COVID-19 and Related Developments
    • 7.7 Physio-Control International
      • 7.7.1 Physio-Control International Business Overview
      • 7.7.2 Physio-Control International Implantable Cardioverter Defibrillator (ICD) Quarterly Production and Revenue, 2020
      • 7.7.3 Physio-Control International Implantable Cardioverter Defibrillator (ICD) Product Introduction
      • 7.7.4 Physio-Control International Response to COVID-19 and Related Developments
    • 7.8 Cardiac Science
      • 7.8.1 Cardiac Science Business Overview
      • 7.8.2 Cardiac Science Implantable Cardioverter Defibrillator (ICD) Quarterly Production and Revenue, 2020
      • 7.8.3 Cardiac Science Implantable Cardioverter Defibrillator (ICD) Product Introduction
      • 7.8.4 Cardiac Science Response to COVID-19 and Related Developments
    • 7.9 Sorin Group
      • 7.9.1 Sorin Group Business Overview
      • 7.9.2 Sorin Group Implantable Cardioverter Defibrillator (ICD) Quarterly Production and Revenue, 2020
      • 7.9.3 Sorin Group Implantable Cardioverter Defibrillator (ICD) Product Introduction
      • 7.9.4 Sorin Group Response to COVID-19 and Related Developments
    • 7.10 Nihon Kohden
      • 7.10.1 Nihon Kohden Business Overview
      • 7.10.2 Nihon Kohden Implantable Cardioverter Defibrillator (ICD) Quarterly Production and Revenue, 2020
      • 7.10.3 Nihon Kohden Implantable Cardioverter Defibrillator (ICD) Product Introduction
      • 7.10.4 Nihon Kohden Response to COVID-19 and Related Developments
    • 7.11 Shree Pacetronix Ltd.
      • 7.11.1 Shree Pacetronix Ltd. Business Overview
      • 7.11.2 Shree Pacetronix Ltd. Implantable Cardioverter Defibrillator (ICD) Quarterly Production and Revenue, 2020
      • 7.11.3 Shree Pacetronix Ltd. Implantable Cardioverter Defibrillator (ICD) Product Introduction
      • 7.11.4 Shree Pacetronix Ltd. Response to COVID-19 and Related Developments
    • 7.12 EBR Systems
      • 7.12.1 EBR Systems Business Overview
      • 7.12.2 EBR Systems Implantable Cardioverter Defibrillator (ICD) Quarterly Production and Revenue, 2020
      • 7.12.3 EBR Systems Implantable Cardioverter Defibrillator (ICD) Product Introduction
      • 7.12.4 EBR Systems Response to COVID-19 and Related Developments
    • 7.13 MEDICO S.p.A.
      • 7.13.1 MEDICO S.p.A. Business Overview
      • 7.13.2 MEDICO S.p.A. Implantable Cardioverter Defibrillator (ICD) Quarterly Production and Revenue, 2020
      • 7.13.3 MEDICO S.p.A. Implantable Cardioverter Defibrillator (ICD) Product Introduction
      • 7.13.4 MEDICO S.p.A. Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Implantable Cardioverter Defibrillator (ICD) Supply Chain Analysis
      • 8.1.1 Implantable Cardioverter Defibrillator (ICD) Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Implantable Cardioverter Defibrillator (ICD) Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Implantable Cardioverter Defibrillator (ICD) Distribution Channels
      • 8.2.2 Covid-19 Impact on Implantable Cardioverter Defibrillator (ICD) Distribution Channels
      • 8.2.3 Implantable Cardioverter Defibrillator (ICD) Distributors
    • 8.3 Implantable Cardioverter Defibrillator (ICD) Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Implantable Cardioverter Defibrillator (ICD), including the following market information:
      Global Implantable Cardioverter Defibrillator (ICD) Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Implantable Cardioverter Defibrillator (ICD) Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Implantable Cardioverter Defibrillator (ICD) Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Implantable Cardioverter Defibrillator (ICD) Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Medtronic, Abbott, Boston Scientific, Philips Healthcare, Zoll Medical, Biotronik Se, Physio-Control International, Cardiac Science, Sorin Group, Nihon Kohden, Shree Pacetronix Ltd., EBR Systems, MEDICO S.p.A., etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Single Chamber ICD
      Dual Chamber ICD
      Biventricular ICD

      Based on the Application:
      Bradycardia
      Tachycardia
      Heart Failure
      Others

      Buy now